EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nova Pharma Solutions Bhd's Enterprise Value is RM25.97 Mil.
Nova Pharma Solutions Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was RM6.52 Mil. Therefore, Nova Pharma Solutions Bhd's EV-to-FCF for today is 3.98.
The historical rank and industry rank for Nova Pharma Solutions Bhd's EV-to-FCF or its related term are showing as below:
XKLS:03006'
s EV-to-FCF Range Over the Past 10 Years
Min: -37.08 Med: 10.14 Max: 59.23
Current: 3.98
During the past 9 years, the highest EV-to-FCF of Nova Pharma Solutions Bhd was 59.23. The lowest was -37.08. And the median was 10.14.
XKLS:03006's EV-to-FCF is not ranked
in the Construction industry.
Industry Median: 13.935
vs XKLS:03006: 3.98
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nova Pharma Solutions Bhd's EV-to-FCF
For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Pharma Solutions Bhd's EV-to-FCF Distribution in the Construction Industry
For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nova Pharma Solutions Bhd's EV-to-FCF falls into.
Nova Pharma Solutions Bhd's current Enterprise Value is RM25.97 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Pharma Solutions Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was RM6.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Pharma Solutions Bhd (XKLS:03006) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Nova Pharma Solutions Bhd's PE Ratio for today is calculated as:
Nova Pharma Solutions Bhd's share price for today is RM0.23.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Pharma Solutions Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was RM0.026.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nova Pharma Solutions Bhd EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Nova Pharma Solutions Bhd (XKLS:03006) Business Description
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:03006 has been successfully added to your 